CereVasc

"We are excited to welcome Shlomi Nachman and Timothy Scannell to the CereVasc Board. They both bring a wealth of experience in the medical device and neurovascular fields and have distinguished careers in leading prominent medical device organizations. We look forward to leveraging their expertise and insights to bring the eShunt System to the market." https://lnkd.in/eH9WaBfa

Congratulations to Dr. Christopher S. Ogilvy and the Beth Israel Deaconess Medical Center team on their first eShunt® System case in the US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial, the first eShunt System case performed in CereVasc's hometown of Boston!

Huge congratulations to Dr. Ricardo Hanel and the Baptist Health team on another successful case in the NPH pilot study which represents the 50th eShunt® procedure performed to date, a major milestone. A very special thanks to Dr. Ivan Lylyk and the entire ENERI - Dr. Pedro Lylyk team for your support of today's case and your contributions to achieving this milestone.

Excellent talk this morning by Dr. Charles Matouk at Westchester Medical Center, a member of WMCHealth's New York Symposium on Innovation in Neuroscience at the historic New York Academy of Medicine!

Congratulations to Dr. John Reavey-Cantwell and team on their first eShunt® System case in the US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!

Congratulations to Dr. Tarun Bhalla and the University of Rochester Medical Center team on their first eShunt® System case in the US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!

El Dr. Pedro Lylyk recibió una invitación especial de la Universidad de Toronto en conmemoración del centenario del Departamento de Neurocirugía de la universidad, y en este marco, la institución tuvo el gesto de invitar a sus estudiantes más destacados🧠👨⚕️. El sábado 25 de mayo, el Dr. Lylyk participó como invitado de honor en el Congreso CNSF 2024, organizado por la Federación Canadiense de Ciencias Neurológicas, en la vibrante Ciudad de Toronto, Canadá. Este evento conmemoró el centenario del Departamento de Neurocirugía de la Universidad de Toronto. El Dr. Lylyk abordó un tema de gran relevancia: "Tratamiento Endovascular de la Hidrocefalia" ("Endovascular Treatment of Hydrocephalus"). Su participación no solo enriqueció el congreso, sino que también destacó su expertise en este campo crucial de la medicina🩺🧠. #Sagrada_BsAs #ENERI

We are thrilled by the support of Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund to continue the clinical and regulatory development of the eShunt® System including the execution of the STRIDE pivotal study in Normal Pressure Hydrocephalus. #seriesb #hydrocephalus #pivotaltrial #neurovascular https://lnkd.in/gHQf-3TW

"FDA approval of the STRIDE study is a significant milestone for CereVasc. The team has worked tirelessly to develop the eShunt® System and we believe STRIDE will result in clinical data to support the use of our system in the treatment of patients with Normal Pressure Hydrocephalus (NPH)." #hydrocephalus #neurovascular #NPH #pivotalstudy https://lnkd.in/ev7cybPQ

Congratulations to Dr. Ricardo Hanel and the Baptist Health team on their first eShunt System case in the US Pilot Study of the CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!